Proposed Data Collection Submitted for Public Comment and Recommendations, 66899-66901 [2019-26371]

Download as PDF Federal Register / Vol. 84, No. 235 / Friday, December 6, 2019 / Notices submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. ATSDR will carefully consider all comments submitted in preparation of the final Toxicological Profiles and may revise the profiles as appropriate. The Superfund Amendments and Reauthorization Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency (EPA) regarding the hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare toxicological profiles for each substance included on the priority list of hazardous substances [also called the Substance Priority List (SPL)]. This list identifies 275 hazardous substances that ATSDR and EPA have determined pose the most significant potential threat to human health. The SPL is available online at www.atsdr.cdc.gov/spl. In addition, CERCLA provides ATSDR with the authority to prepare toxicological profiles for substances not found on the SPL. CERCLA authorizes ATSDR to establish and maintain an inventory of literature, research, and studies on the health effects of toxic substances (CERCLA Section 104(i)(1)(B); 42 U.S.C. 9604(i)(1)(B)); to respond to requests for health consultations (CERCLA Section 104(i)(4); 42 U.S.C. 9604(i)(4)); and to support the site-specific response actions conducted by the agency. Availability lotter on DSKBCFDHB2PROD with NOTICES These Draft Toxicological Profiles will be available online at http:// www.atsdr.cdc.gov/ToxProfiles and at www.regulations.gov, Docket No. ATSDR–0008. Pamela I. Protzel Berman, Director, Office of Policy, Partnerships and Planning, Agency for Toxic Substances and Disease Registry. [FR Doc. 2019–26361 Filed 12–5–19; 8:45 am] BILLING CODE 4163–70–P 16:11 Dec 05, 2019 Centers for Disease Control and Prevention [60Day–20–0263; Docket No. CDC–2019– 0110] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS) ACTION: Notice with comment period. AGENCY: Legislative Background VerDate Sep<11>2014 DEPARTMENT OF HEALTH AND HUMAN SERVICES Jkt 250001 The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on Requirements for the Importation of Nonhuman Primates into the United States. This information collection contains the reporting and documentation requirements for registered importers of nonhuman primates, as outlined in 42 Code of Federal Regulations part 71.53 Requirements for importers of nonhuman primates. DATES: CDC must receive written comments on or before February 4, 2020. ADDRESSES: You may submit comments, identified by Docket No. CDC–2019– 0110 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. SUMMARY: Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, of the Information Collection Review Office, Centers for Disease Control and FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 66899 Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project Requirements for the Importation of Nonhuman Primates into the United States (OMB Control No. 0920–0263, Exp. 08/31/2020)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description Under the 42 CFR 71.53, CDC collects information pertaining to importers and imported nonhuman primates. This information collection enables CDC to evaluate compliance with pre-arrival of shipment notification requirements, to investigate the number and species of imported nonhuman primates, and to E:\FR\FM\06DEN1.SGM 06DEN1 66900 Federal Register / Vol. 84, No. 235 / Friday, December 6, 2019 / Notices determine if adequate measures are being taken for the prevention of exposure to persons and animals during importation. Since May 1990, CDC has monitored the arrival and/or uncrating of certain shipments of non-human primates imported in to the United States. In February 2013, CDC promulgated two regulations pertaining to the importation of nonhuman primates. The first rule, Establishment of User Fees for Filovirus Testing of Nonhuman Primate Liver Samples, outlines a process by which importers can send liver tissues to CDC from primates that die during importation from reasons other than trauma (2/12/2013, Vol.78, No. 29, p.9828). CDC performs these tests due to the absence of a private sector option. The second rule, Requirements for Importers of Nonhuman Primates, consolidates into 42 CFR 71.53 the requirements previously found in 42 CFR part 71.53 with those found in the Special Permit to Import Cynomolgus, African Green, or Rhesus Monkeys into the United States (2/15/2013, Vol. 78, No. 32/p. 11522). It also rescinded the six-month special-permit requirements for cynomolgus, African green, and rhesus monkeys and extended the time period for registration/permit renewal from 180 days to two years, reducing much of the respondent burden. CDC feels these regulatory changes and reporting requirements balance the public health risks posed by the importation of nonhuman primates with the burden imposed on regulating their importation. All registered importers of nonhuman primates are required by 42 CFR part 71.53 to maintain certain disease control procedures and keep certain records. Standard business practices likely dictate that importers already keep records on the origin, transportation, and disposition of the nonhuman primates. Thus, CDC asks for information which should already be maintained by the importers and need only be assembled and reported. The estimate of burden hours and costs reflects assembling and reporting only. CDC requests approval for an estimated 185 annual burden hours. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Nonhuman Primate Importer. Nonhuman Primate Importer. Nonhuman Primate Importer. Nonhuman Primate Importer. Nonhuman Primate Importer. Nonhuman Primate Importer. Nonhuman Primate Importer. Nonhuman Primate Importer. Nonhuman Primate Importer. Total ........................ Number of responses per respondent Number of respondents Form name/CFR reference CDC 75.10A Application for Registration as an Importer of Nonhuman Primates (New Importer). CDC 75.10A Application for Registration as an Importer of Nonhuman Primates (Re-Registration). 71.53(g)(1)(iii) and (h) Documentation and Standard Operating Procedures (no form) (New Importer). 71.53(g)(1)(iii) and (h) Documentation and Standard Operating Procedures (no form) (Registered Importer). Recordkeeping and reporting requirements for importing NHPs: Notification of shipment arrival 71.53(n) (no form). Statements regarding the health of the nonhuman primates during travel and CDC quarantine (42 CFR 71.53(m) (no form). Statements, including necropsy reports, about the nonhuman primates upon their release from CDC quarantine. (42 CFR 71.53(m)(no form). Quarantine release 71.53(l)(no form) .................. 1 10/60 1 12 1 10/60 2 1 1 10 10 12 1 30/60 6 25 6 15/60 38 25 6 15/60 38 25 3 15/60 19 25 6 15/60 38 71.53 (v) Form: Filovirus Diagnostic Specimen Submission Form for Non-human Primate Materials. 10 10 20/60 33 .............................................................................. ........................ ........................ ........................ 185 [FR Doc. 2019–26371 Filed 12–5–19; 8:45 am] lotter on DSKBCFDHB2PROD with NOTICES Total burden hours 1 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P VerDate Sep<11>2014 Average burden per response (in hours) 17:22 Dec 05, 2019 Jkt 250001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\06DEN1.SGM 06DEN1 Federal Register / Vol. 84, No. 235 / Friday, December 6, 2019 / Notices Centers for Disease Control and Prevention [60Day–20–1193; Docket No. CDC–2019– 0105] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Assessment of Technical Assistance and Training (TTA) Approaches to Accelerate Comprehensive Cancer Control Outcomes. CDC is requesting to collect information about TTA offered using case studies and a web-based survey to assess whether a specific cooperative agreement has been implemented as intended, and has contributed to National Comprehensive Cancer Control Program (NCCCP) awardees’ achievements in program goals and outcomes. SUMMARY: CDC must receive written comments on or before February 4, 2020. DATES: You may submit comments, identified by Docket No. CDC–2019– 0105 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. lotter on DSKBCFDHB2PROD with NOTICES ADDRESSES: Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. VerDate Sep<11>2014 17:22 Dec 05, 2019 Jkt 250001 To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF HEALTH AND HUMAN SERVICES Proposed Project Assessment of Technical Assistance and Training (TTA) Approaches to Accelerate Comprehensive Cancer Control Outcomes (OMB Control No. 0920–1193)—Reinstatement with Change—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 66901 Background and Brief Description Cancer is the second leading cause of death in the United States, and health care costs for cancer care are expected to rise to $158 billion by 2020. Addressing this public health problem requires primary prevention, early detection and treatment, support for cancer survivors, and a reduction in health disparities. Providing support to state, tribal, territorial and local organizations to implement evidencebased strategies has the potential to impact population-level cancer outcomes and reduce the burden of cancer. The Centers for Disease Control and Prevention’s (CDC) National Comprehensive Cancer Control Program (NCCCP) has been a primary funder for state and community-based cancer control interventions since its inception in the late 1990s. The program supports states and communities in developing a comprehensive approach to cancer prevention and control that includes supporting an infrastructure for state, local, and population-based interventions and multi-sectoral partnerships and coalitions. Currently, NCCCP supports 66 cancer control program grantees including programs in all 50 states, the District of Columbia, and in a number of tribes, tribal organizations, and U.S. Associated Pacific Islands/territories. In addition, CDC’s Office on Smoking and Health (OSH) also has worked to build state health department infrastructure and capacity to conduct coordinated comprehensive tobacco prevention and control activities which contribute to cancer health outcomes. In striving to build capacity and maximize the impact of CDC’s funded programs, CDC has focused on developing and implementing innovative programs to enhance TTA delivered to NCCCP awardees. CDC funds two awardees under a cooperative agreement—Provision of Technical Assistance and Training to Assure Comprehensive Cancer Control Outcomes (DP18–1805). DP18–1805 awardees are charged with developing and delivering high-quality TTA for NCCCP funded programs, coalition members, and partners focused on improving implementation of evidencebased strategies for cancer prevention and control. The TTA activities DP18– 1805 awardees implement include; (1) conducting needs assessments, (2) E:\FR\FM\06DEN1.SGM 06DEN1

Agencies

[Federal Register Volume 84, Number 235 (Friday, December 6, 2019)]
[Notices]
[Pages 66899-66901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26371]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-20-0263; Docket No. CDC-2019-0110]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS)

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on Requirements for 
the Importation of Nonhuman Primates into the United States. This 
information collection contains the reporting and documentation 
requirements for registered importers of nonhuman primates, as outlined 
in 42 Code of Federal Regulations part 71.53 Requirements for importers 
of nonhuman primates.

DATES: CDC must receive written comments on or before February 4, 2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0110 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed 
above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, of the Information 
Collection Review Office, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-
7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Requirements for the Importation of Nonhuman Primates into the 
United States (OMB Control No. 0920-0263, Exp. 08/31/2020)--Revision--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Under the 42 CFR 71.53, CDC collects information pertaining to 
importers and imported nonhuman primates. This information collection 
enables CDC to evaluate compliance with pre-arrival of shipment 
notification requirements, to investigate the number and species of 
imported nonhuman primates, and to

[[Page 66900]]

determine if adequate measures are being taken for the prevention of 
exposure to persons and animals during importation.
    Since May 1990, CDC has monitored the arrival and/or uncrating of 
certain shipments of non-human primates imported in to the United 
States. In February 2013, CDC promulgated two regulations pertaining to 
the importation of nonhuman primates. The first rule, Establishment of 
User Fees for Filovirus Testing of Nonhuman Primate Liver Samples, 
outlines a process by which importers can send liver tissues to CDC 
from primates that die during importation from reasons other than 
trauma (2/12/2013, Vol.78, No. 29, p.9828). CDC performs these tests 
due to the absence of a private sector option. The second rule, 
Requirements for Importers of Nonhuman Primates, consolidates into 42 
CFR 71.53 the requirements previously found in 42 CFR part 71.53 with 
those found in the Special Permit to Import Cynomolgus, African Green, 
or Rhesus Monkeys into the United States (2/15/2013, Vol. 78, No. 32/p. 
11522). It also rescinded the six-month special-permit requirements for 
cynomolgus, African green, and rhesus monkeys and extended the time 
period for registration/permit renewal from 180 days to two years, 
reducing much of the respondent burden. CDC feels these regulatory 
changes and reporting requirements balance the public health risks 
posed by the importation of nonhuman primates with the burden imposed 
on regulating their importation.
    All registered importers of non-human primates are required by 42 
CFR part 71.53 to maintain certain disease control procedures and keep 
certain records. Standard business practices likely dictate that 
importers already keep records on the origin, transportation, and 
disposition of the nonhuman primates. Thus, CDC asks for information 
which should already be maintained by the importers and need only be 
assembled and reported. The estimate of burden hours and costs reflects 
assembling and reporting only. CDC requests approval for an estimated 
185 annual burden hours. There is no cost to respondents other than 
their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                              Average
                                                                                             Number of       Number of      burden per     Total burden
              Type of  respondent                        Form name/CFR reference            respondents    responses per   response  (in       hours
                                                                                                            respondent        hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Nonhuman Primate Importer......................  CDC 75.10A Application for Registration               1               1           10/60               1
                                                  as an Importer of Nonhuman Primates
                                                  (New Importer).
Nonhuman Primate Importer......................  CDC 75.10A Application for Registration              12               1           10/60               2
                                                  as an Importer of Nonhuman Primates
                                                  (Re-Registration).
Nonhuman Primate Importer......................  71.53(g)(1)(iii) and (h) Documentation                1               1              10              10
                                                  and Standard Operating Procedures (no
                                                  form) (New Importer).
Nonhuman Primate Importer......................  71.53(g)(1)(iii) and (h) Documentation               12               1           30/60               6
                                                  and Standard Operating Procedures (no
                                                  form) (Registered Importer).
Nonhuman Primate Importer......................  Recordkeeping and reporting                          25               6           15/60              38
                                                  requirements for importing NHPs:
                                                  Notification of shipment arrival
                                                  71.53(n) (no form).
Nonhuman Primate Importer......................  Statements regarding the health of the               25               6           15/60              38
                                                  nonhuman primates during travel and
                                                  CDC quarantine (42 CFR 71.53(m) (no
                                                  form).
Nonhuman Primate Importer......................  Statements, including necropsy reports,              25               3           15/60              19
                                                  about the nonhuman primates upon their
                                                  release from CDC quarantine. (42 CFR
                                                  71.53(m)(no form).
Nonhuman Primate Importer......................  Quarantine release 71.53(l)(no form)...              25               6           15/60              38
Nonhuman Primate Importer......................  71.53 (v) Form: Filovirus Diagnostic                 10              10           20/60              33
                                                  Specimen Submission Form for Non-human
                                                  Primate Materials.
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............             185
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-26371 Filed 12-5-19; 8:45 am]
 BILLING CODE 4163-18-P